BodeVet
BodeVet is dedicated to solving unmet needs in companion and exotic animal transfusion medicine and regenerative therapies. Built on socially responsible sourcing, cGMP manufacturing, and product consistency, BodeVet develops innovative blood products to improve clinical outcomes in veterinary medicine. Their mission includes developing novel blood products for hemostasis and regenerative medicine, with a focus on safety, efficacy, and social responsibility.
Industries
Nr. of Employees
small (1-50)
Products
Freeze-dried platelet-derived hemostatic agent (canine formulation)
A trehalose-stabilized, freeze-dried platelet-derived preparation supplied as a dry powder for reconstitution and IV infusion at point of care to treat thrombocytopenia- or trauma-related hemorrhage in dogs.
Lyophilized plasma formulation for veterinary trauma resuscitation
A dried plasma product intended for reconstitution and use in trauma resuscitation to support hemodynamic stabilization in veterinary patients.
Freeze-dried platelet preparations for zoo and wildlife applications (developmental)
Development-stage freeze-dried platelet products proposed for use in exotic and wildlife species (e.g., elephants) to address acute thrombocytopenia and hemorrhage in zoo medicine and conservation contexts.
Freeze-dried platelet-derived hemostatic agent (canine formulation)
A trehalose-stabilized, freeze-dried platelet-derived preparation supplied as a dry powder for reconstitution and IV infusion at point of care to treat thrombocytopenia- or trauma-related hemorrhage in dogs.
Lyophilized plasma formulation for veterinary trauma resuscitation
A dried plasma product intended for reconstitution and use in trauma resuscitation to support hemodynamic stabilization in veterinary patients.
Freeze-dried platelet preparations for zoo and wildlife applications (developmental)
Development-stage freeze-dried platelet products proposed for use in exotic and wildlife species (e.g., elephants) to address acute thrombocytopenia and hemorrhage in zoo medicine and conservation contexts.
Services
Design and conduct of multicenter randomized safety and efficacy trials of veterinary blood-derived therapeutics at critical care hospitals.
Management and execution of government-sponsored and partner-funded studies evaluating lyophilized blood products in trauma and conservation contexts.
Manufacturing services and process development under current Good Manufacturing Practices for blood-derived veterinary products.
On-site provision of therapeutic plasma exchange, cytapheresis, and autologous platelet collection performed in veterinary hospitals, with selective processing for cellular therapies.
Design and conduct of multicenter randomized safety and efficacy trials of veterinary blood-derived therapeutics at critical care hospitals.
Management and execution of government-sponsored and partner-funded studies evaluating lyophilized blood products in trauma and conservation contexts.
Manufacturing services and process development under current Good Manufacturing Practices for blood-derived veterinary products.
On-site provision of therapeutic plasma exchange, cytapheresis, and autologous platelet collection performed in veterinary hospitals, with selective processing for cellular therapies.
Expertise Areas
- Veterinary transfusion medicine
- Lyophilized blood product development
- Preclinical animal model studies and safety assessment
- Multicenter clinical trial management for veterinary therapeutics
Key Technologies
- Lyophilization (freeze-drying) with trehalose stabilization
- Platelet-derived hemostatic formulations
- Lyophilized plasma formulations
- Thromboelastography (TEG)
News & Updates
Study will evaluate administration and effects of freeze-dried platelets and plasma.
The in-human care population of elephants is plagued by an endotheliotropic herpes virus that attacks young elephants and causes an acute loss of platelets with associated bleeding. BodeVet, Inc. working with the Smithsonian Institute has begun the process of producing lyophilized platelets for zoos to have available when bleeding occurs.
Wounds treated with multiple doses of VEGF and a single dose of freeze-dried platelets reached 90% closure faster than wounds left untreated. A single administration of trehalose lyophilized and reconstituted platelets showed promising results.
Study to determine whether platelet growth factors are preserved in supernatants from rehydrated trehalose-stabilized, freeze-dried equine platelets and whether these factors stimulate fibroblast proliferation, migration, and contraction.
Study will evaluate administration and effects of freeze-dried platelets and plasma.
The in-human care population of elephants is plagued by an endotheliotropic herpes virus that attacks young elephants and causes an acute loss of platelets with associated bleeding. BodeVet, Inc. working with the Smithsonian Institute has begun the process of producing lyophilized platelets for zoos to have available when bleeding occurs.
Wounds treated with multiple doses of VEGF and a single dose of freeze-dried platelets reached 90% closure faster than wounds left untreated. A single administration of trehalose lyophilized and reconstituted platelets showed promising results.
Study to determine whether platelet growth factors are preserved in supernatants from rehydrated trehalose-stabilized, freeze-dried equine platelets and whether these factors stimulate fibroblast proliferation, migration, and contraction.